What is it used for?
REBLOZYL is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts …REBLOZYL is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts …
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- luspaterceptluspatercept
- Form and strength
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 25 mg; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 75 mgINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 25 mg; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 75 mg
- Manufacturer / applicant
- CELGENE CORPORATIONCELGENE CORPORATION
•For injection: 25 mg white to off-white lyophilized powder in a single-dose vial for reconstitution. •For injection: 75 mg white to off-white lyophilized powder in a single-dose vial for reconstitution.•For injection: 25 mg white to off-white lyophilized powder in a single-dose vial for reconstitution. •For injection: 75 mg white to off-white lyophilized powder in a single-dose vial for reconstitution.
Safety and clinical review
- Thrombosis/ThromboembolismThrombosis/Thromboembolism
- HypertensionHypertension
- Extramedullary Hematopoietic MassesExtramedullary Hematopoietic Masses
- Embryo-Fetal ToxicityEmbryo-Fetal Toxicity
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Reblozyl used for?
REBLOZYL is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts …REBLOZYL is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions. REBLOZYL is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts …
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Reblozyl should I ask about?
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 25 mg; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 75 mgINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 25 mg; INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · 75 mg
Read the primary sourceWhat determines the price of Reblozyl?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Reblozyl?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.